Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqCM:MLTX
NasdaqCM:MLTXBiotechs

How MoonLake’s Phase 3 Sonelokimab HiSCR75 Data in HS Could Shape MoonLake Immunotherapeutics (MLTX) Investors

MoonLake Immunotherapeutics recently reported long-term Week 40 Phase 3 VELA-1 and VELA-2 data for sonelokimab in moderate-to-severe hidradenitis suppurativa, showing strong efficacy on HiSCR75 and quality-of-life endpoints with a stable safety profile. An interesting feature of these results is the use of a higher HiSCR75 threshold as the primary endpoint, positioning sonelokimab against existing IL-17A and IL-17A/F therapies on a more stringent efficacy measure. We’ll now examine how...
NYSE:WS
NYSE:WSMetals and Mining

Assessing Worthington Steel (WS) Valuation After Q3 Earnings Update And Dividend Reaffirmation

Worthington Steel (WS) is back in focus after reporting third quarter results that showed higher sales but lower quarterly net income compared with a year earlier, along with higher nine-month earnings and a reaffirmed quarterly dividend. See our latest analysis for Worthington Steel. The latest results and dividend decision come after a mixed price pattern, with a 5.05% 7 day share price return, a 19.61% 30 day share price decline, and a 31.76% 1 year total shareholder return, suggesting...
SEHK:1898
SEHK:1898Oil and Gas

Assessing China Coal Energy’s Valuation After Weaker Earnings And A Lower Final Dividend Proposal

Why China Coal Energy’s latest earnings and dividend proposal matter China Coal Energy (SEHK:1898) has moved back into focus after releasing its full year 2025 results, alongside a proposal for an ordinary final dividend of RMB 0.217 per share and an upcoming earnings call. The new figures, including sales of CNY 147,120.98 million, revenue of CNY 148,056.7 million and net income of CNY 17,883.58 million, provide updated data to assess profitability, income potential and valuation. See our...
NasdaqGS:GILT
NasdaqGS:GILTCommunications

Does Gilat Satellite Networks' (GILT) New U.S. Army Orders Reframe Its Defense-Led Connectivity Strategy?

In March 2026, Gilat Satellite Networks’ Gilat DataPath unit reported receiving about US$6,000,000 in new orders over six months to continue providing field and technical services that support U.S. Army global communications operations under the GTACS II contract vehicle. This extension deepens Gilat’s multi-year role in mission-critical U.S. defense communications, underscoring the company’s position as a trusted supplier of resilient connectivity for military operations. We’ll now examine...
NasdaqGS:PDFS
NasdaqGS:PDFSSemiconductor

Is PDF Solutions (PDFS) Quietly Becoming a Core Data Layer for Complex Chip Manufacturing?

Recent commentary highlights how PDF Solutions has been benefiting from AI-led digital transformation, as customers increasingly adopt its cloud-enabled software, unified data platforms, and real-time analytics to manage more complex semiconductor manufacturing. An important insight is that rising investments in 3D manufacturing, AI-driven collaboration, and geographic diversification are amplifying demand for PDF Solutions’ consulting, research, cybersecurity, and compliance-focused...
OB:NORBT
OB:NORBTElectronic

European Value Stocks Offering Estimated Opportunities In April 2026

As European markets experience a boost in sentiment due to hopes for a shorter-lived Middle East conflict, the pan-European STOXX Europe 600 Index has risen by 3.92%, reflecting optimism across the region. In this context, identifying undervalued stocks can be particularly rewarding as they offer potential opportunities for growth amid fluctuating energy prices and inflationary pressures.
OM:NETI B
OM:NETI BCommunications

European Market Insights: Turbomecanica And 2 Other Promising Penny Stocks

The European market has seen a notable uptick, with the pan-European STOXX Europe 600 Index climbing 3.92% amid optimism that Middle East tensions might ease sooner than anticipated. Amidst such market movements, investors often seek opportunities in lesser-known areas like penny stocks—an investment category that remains relevant for those looking to uncover potential value in smaller or newer companies. While the term "penny stock" may seem outdated, these investments can still offer...
NasdaqGS:SOLS
NasdaqGS:SOLSChemicals

Why Solstice Advanced Materials (SOLS) Is Up 7.8% After Hudson Licensing Deal For HFO Refrigerants

In late March 2026, Hudson Technologies announced a licensing agreement with Solstice Advanced Materials to reclaim and resell Solstice’s patented lower-GWP HFO refrigerant blends R-448A and R-449A across the United States and Canada under AIM Act-compliant applications in the supermarket segment. This agreement gives Solstice broader access to the refrigeration retrofit market while aligning its technology with tightening environmental regulations on higher-GWP refrigerants. Next, we’ll...
TSXV:PLSR
TSXV:PLSROil and Gas

Does Pulsar Helium's (TSXV:PLSR) New U.S.-Focused President Reframe Its Commercial Strategy Narrative?

Pulsar Helium Inc. has appointed helium-sector specialist Cliff Cain as President, effective April 1, 2026, following his prior role leading commercial and external affairs and his involvement in Minnesota gas legislation, while director Brice Laurent resigned on March 31, 2026. Cain’s promotion signals a sharper emphasis on U.S.-focused commercial development, government engagement and future offtake preparation across helium-dependent industries. We’ll now examine how Cain’s U.S.-centric...
NasdaqGM:PAYO
NasdaqGM:PAYODiversified Financial

Assessing Payoneer Global (PAYO) Valuation After BofA’s New Positive Coverage And Growth Outlook

Why BofA’s New Coverage Matters For Payoneer Global (PAYO) BofA’s decision to initiate coverage of Payoneer Global (PAYO) with a favorable view puts fresh attention on the stock and highlights its role in cross border payments for small and medium sized businesses. See our latest analysis for Payoneer Global. Despite BofA’s positive coverage, momentum has been mixed. There has been a 7 day share price return of 3.14% and a 30 day share price return of 4.68%, set against a 1 year total...
NasdaqGS:COLL
NasdaqGS:COLLPharmaceuticals

How Prospective US Tariffs on Branded Drug Imports Will Impact Collegium Pharmaceutical (COLL) Investors

In early April 2026, reports that the US government may impose tariffs of up to 100% on imports of branded and patented drugs, focusing on companies that have not agreed to lower prices, triggered a broad reassessment of regulatory and cost risks across the pharmaceutical industry. This policy debate matters for Collegium Pharmaceutical because it highlights how fast-changing US drug-pricing and trade actions can influence sentiment toward specialty pain and CNS drug makers, even when their...
TWSE:2301
TWSE:2301Tech

High Growth Tech Stocks In Asia To Watch April 2026

As geopolitical tensions in the Middle East continue to influence global markets, Asian tech stocks are navigating a complex landscape marked by both volatility and opportunity. In this environment, high-growth tech companies in Asia that demonstrate resilience through innovation and adaptability to shifting economic conditions are particularly worth watching.
SEHK:1768
SEHK:1768Consumer Retailing

Asian Market Stocks That May Be Trading Below Their Estimated Value

Amidst ongoing geopolitical tensions and energy market volatility, Asian markets have been navigating a complex landscape, with indices showing mixed performances as investors assess the impact of these global events. In such an environment, identifying stocks that may be trading below their estimated value can offer potential opportunities for investors looking to capitalize on market inefficiencies.
SEHK:968
SEHK:968Semiconductor

Asian Penny Stocks To Consider In April 2026

Amidst ongoing geopolitical tensions and energy market volatility, Asian markets are navigating a complex landscape with mixed signals from global indices. Penny stocks, though often overlooked, remain an intriguing area of investment for those seeking potential growth in smaller or newer companies. By focusing on firms with strong financial health, investors can uncover opportunities that might offer both stability and potential upside; here we explore three such promising candidates within...
TSE:4432
TSE:4432Software

Asian Dividend Stocks To Enhance Your Portfolio

As global markets navigate geopolitical tensions and energy market volatility, Asian economies are showing resilience, with China's manufacturing sector rebounding and Japan grappling with oil price impacts. In this context, dividend stocks in Asia offer a compelling opportunity for investors seeking stability and income, as they can provide regular returns even amid broader market uncertainties.
NYSE:CYD
NYSE:CYDMachinery

China Yuchai International (CYD) Is Up 8.1% After 40% EPS Upgrade Has The Bull Case Changed?

Recently, analysts raised their full-year earnings projections for China Yuchai International by 40.5%, while the company’s year-to-date return has outpaced both the broader Auto-Tires-Trucks sector and its Automotive - Original Equipment peers. This combination of sharply upgraded earnings expectations and clear relative performance strength suggests analysts and investors are reassessing the company’s profit and competitive outlook. We’ll now explore how this upgrade in earnings...
NYSE:EW
NYSE:EWMedical Equipment

Edwards Lifesciences (EW) Valuation Check After EVOQUE TRISCEND II Results And Growing Regulatory Momentum

Edwards Lifesciences (EW) put fresh clinical data for its EVOQUE tricuspid valve system in the spotlight at the ACC.26 conference, highlighting sustained patient benefits and lower mortality in the TRISCEND II trial. See our latest analysis for Edwards Lifesciences. At a share price of $81.19, Edwards Lifesciences has seen a 17.67% 1 year total shareholder return. The 90 day share price return of a 5.43% decline suggests recent momentum has cooled despite supportive EVOQUE trial headlines. If...
NasdaqGS:SRRK
NasdaqGS:SRRKBiotechs

A Look At Scholar Rock (SRRK) Valuation After Apitegromab BLA Resubmission And Reduced Regulatory Risk

Scholar Rock Holding (SRRK) has resubmitted its Biologics License Application for apitegromab to the FDA, following alignment with regulators on facility remediation and the addition of a second US based fill finish site. See our latest analysis for Scholar Rock Holding. The BLA resubmission appears to have kept attention on Scholar Rock, with a 7 day share price return of 13.3% and an 18.16% 90 day share price return. The 1 year total shareholder return of 87.44% points to strong momentum...
NYSE:ORA
NYSE:ORARenewable Energy

Should Ormat’s 149 MW Geothermal and Storage Expansion Plans Require Action From Ormat Technologies (ORA) Investors?

In recent months, Ormat Technologies has outlined plans to add 149 MW of new capacity by the end of 2027, including 101 MW from geothermal projects, while committing US$180 million to build additional energy storage assets in the United States through 2028. This combination of geothermal expansion and sizable storage investment highlights Ormat’s effort to deepen its role in supplying grid-stable renewable power as adoption of clean energy accelerates. Next, we’ll explore how Ormat’s planned...